Surgery Versus Non-surgical Treatment for Esophageal Squamous Cell Carcinoma in Patients Older Than 70 Years

计划入组 2 人 · 首次发布于 2022 年 11 月 3 日

Nituzumab (Taixinsheng ®） A Prospective, Randomized, Double-blind, Placebo-controlled, Multicenter Phase II Clinical Study on the Efficacy and Safety of Combined Induction Chemotherapy for Locally Advanced Nasopharyngeal Carcinomatreatment of Locally Advanced Nasopharyngeal Carcinoma

计划入组 170 人 · 首次发布于 2022 年 8 月 19 日

Neoadjuvant Chemotherapy and Low-dose Radiotherapy Sequential Concurrent Chemoradiotherapy for Locally Advanced Nasopharyngeal Carcinoma

计划入组 84 人 · 首次发布于 2022 年 3 月 23 日

UT-MeV1

DLL3-CAR-NK Cells

GRP78 inhibitors (Amgen/Cancer Research Technology/Institute of Cancer Research)

West China Hospital of Sichuan University (Sichuan International Hospital)

China

Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital

China

Tianjin Medical University Cancer Institute & Hospital

China

Immunotherapy Plus Chemoradiation Improves Outcomes in Esophageal Cancer

Sichuan Biokin's First-in-Class EGFR/HER3 ADC Advances to Phase 3 Trials Across Multiple Cancer Types

Kelun-Biotech's SKB571 Receives Green Light for Clinical Trials